TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsultTYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Targeting Head and Neck Atopic Dermatitis: Long-Term Outcomes with Tralokinumab
DermConsultTargeting Head and Neck Atopic Dermatitis: Long-Term Outcomes with Tralokinumab
Chronic Hand Eczema: Guideline-Based Strategies for Diagnosis and Management
DermConsultChronic Hand Eczema: Guideline-Based Strategies for Diagnosis and Management
Examining Delgocitinib for Chronic Hand Eczema: Results from the DELTA Trials
DermConsultExamining Delgocitinib for Chronic Hand Eczema: Results from the DELTA Trials
Applying Guidelines to Chronic Hand Eczema Care: A Case-Based Approach
DermConsultApplying Guidelines to Chronic Hand Eczema Care: A Case-Based Approach
Rewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
FCDC Action CenterRewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
- advertisement
CKD-aP or Something Else? Decoding the Diagnosis
MinuteCE®CKD-aP or Something Else? Decoding the Diagnosis
- advertisement
Tailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis
Medical Industry FeatureTailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis
Assessing Cutaneous Squamous Cell Carcinoma in People of Color
Medical Industry FeatureAssessing Cutaneous Squamous Cell Carcinoma in People of Color
- 10/17/2025
- 10/09/2025
- 10/09/2025
- 10/08/2025
- 10/06/2025
- 10/06/2025